Teleflex Incorporated (NYSE:TFX) Q1 2024 Earnings Call Transcript

Operator: And your next question comes from the line of Kristen Stewart from C.L. King. Please go ahead.

Kristen Stewart: Hi, thanks for taking my questions. I just wanted to touch on the Vascular Access business that came in a little bit lighter than what I was expecting. Can you maybe just comment on the performance there in the quarter and what we should expect for the balance of the year?

Liam Kelly: Yes, Kristen, that’s a good observation and a good question. The Endurance recall impacted the Vascular business in Q1, and we’ll anniversary that as we go through Q2. So when you get into Q3, you’ll have a clean look at Vascular. So you should see Vascular improve as you go through the year. The other thing I would say on the Vascular business, the underlying PICC growth was really solid, but that will improve too as we go through the year. I would anticipate seeing PICC volumes pick up as we go through the year. The underlying CVC growth is really solid and we’re really happy with how that’s performing. So all in all, it’s really the insurance anniversarying that and an improved environment for PICCs continuing to grow as you go through the year.

Kristen Stewart: Okay, thank you very much.

Liam Kelly: Sure Kristen.

Operator: And that concludes our Q&A Session for today. I would like to hand back over to Lawrence Keusch for closing remarks.

Lawrence Keusch: Thank you, Paully. And thank you to everyone that joined us on the call today. This concludes the Teleflex Incorporated first quarter 2024 earnings conference call.

Operator: Thank you for joining us. You may now disconnect your lines.